KRT19 and breast cancer: Focusing on the 91 OSNA+ BC patients, we observed that all the 72 cases with negative ALND presented a CK19 mRNA copy number <2000 (range 270–1900) regardless of BC molecular subtypes (Figure 3 panel B).